T 1103/22 (Anti-factor XI antibodies/PROTHIX) of 20.06.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T110322.20240620
- Date of decision
- 20 June 2024
- Case number
- T 1103/22
- Petition for review of
- -
- Application number
- 09766879.2
- IPC class
- C07K 16/36A61K 39/395C07K 14/745
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Use of anti-factor XI antibodies for prevention or treatment of thrombus formation
- Applicant name
- Prothix BV
- Opponent name
- Mathys & Squire LLP
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83
- Keywords
- Sufficiency of disclosure - (no)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.